52 EXECUTIVE WOMEN'S STORIES ON BUSINESS AND LEADERSHIP - A 2019 ANTHOLOGY - AC Immune
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
A 2019 ANTHOLOGY
52 EXECUTIVE WOMEN’S STORIES ON BUSINESS AND LEADERSHIP
A SPECIAL PUBLICATION
We salute PharmaVOICE on the first
anniversary of its Woman of the Week
podcast series featuring women in
our industry who are making an impact
Take On Tomorrow®
TAKE ON TOMORROW is a registered Trademark of Sunovion Pharmaceuticals Inc. SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd.
Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.
©2020 Sunovion Pharmaceuticals Inc. All rights reserved.
sunovion.com
Taren Grom
Editor
PharmaVOICE
IN THE FUTURE THERE WILL BE NO FEMALE LEADERS. THERE
WILL JUST BE LEADERS. — SHERYL SANDBERG
Welcome to the inaugural so generous and open to
Woman of the Week sharing their leadership
Anthology, a collection of and career journeys,
52 stories showcasing 52 and exposing their
extraordinary leaders vulnerabilities. Many
representing all facets of our storytellers
of the life-sciences also relate their very
industry. This special personal reasons for
ebook is an extension of joining the healthcare
the popular WoW podcast ecosystem and desire to
series that launched Jan. 2, make a difference.
2019. Many of these women are true
After attending conference after vanguards, having broken through
conference, meeting after meeting, gender and racial barriers, clearing
featuring “manel” after “manel,” a path for the next generation of
we recognized that there was a women to come. We learn from
real need to provide a vehicle for them what it was like to have been
women to tell their stories and share the only women in the room, how
their expertise with the industry. they overcame barriers, and other
In keeping with the PharmaVOICE lessons learned along the way.
brand, we are honored and happy to The profiles featured in this
provide a vehicle for women to raise anthology are just a snap-shot of
their voices. their WoW stories. If you have not
The 52 women featured in the first yet listened to their podcasts, we
year of the series share a common encourage you to do so. We have
ambition: helping patients. They are provided a link to each of their
creating new pathways, developing recordings at the bottom of every
the next generation of talent, profile page.
influencing decisions — big and We hope you enjoy getting to
small, launching new companies, know these women as much as
setting the strategic direction for we have. And we are pleased
multinational organizations. In to continue this series in 2020.
essence they are framing the future Check out the current catalog of
of the life-sciences industry. inspiring podcasts at https://www.
We thank these women for being pharmavoice.com/wow-podcasts. m
Copyright: Unless otherwise agreed in writing, PharmaVOICE retains all rights on material published in PharmaVOICE and
its Special Publications, including both digital and print reprint rights. E-mail: kathy@pharmavoice.com to purchase rights.
WoW Woman of the Week • a 2019 Anthology 3 March 2020 • a Special PharmaVOICE Publication
Woman of the Week
A 2019 ANTHOLOGY
TABLE OF CONTENTS
Click on name to go to article.
Jan. 2, 2019 Maria Fardis, Ph.D., Iovance July 3, 2019 Anjum Swaroop, Dr. Reddy’s
Biotherapeutics Inc. Laboratories
Jan. 9, 2019 Wendy White, RareiTi July 10, 2019 Paula Ragan, Ph.D., X4 Pharmaceuticals
Jan. 16, 2019 Rachel King, GlycoMimetics Inc. July 17, 2019 Charlotte Jones-Burton, M.D., Bristol-
Myers Squibb
Jan 23, 2019 Jennifer De Camara, Johnson & Johnson
July 24, 2019 Janet Kosloff, InCrowd
Jan. 30, 2019 Lynn O’Connor Vos, Muscular Dystrophy
Association July 31, 2019 Kim Johnson, GSW
Feb. 6, 2019 Amy Heymans, Mad*Pow Aug. 7, 2019 Terri Phillips, M.D., Merz North America
Feb. 13, 2019 Georgia Mitsi, Ph.D., Sunovion Aug. 14, 2019 Elizabeth Pinto, Acadia Pharmaceuticals
Pharmaceuticals
Aug. 21, 2019 Lan Huang, Ph.D., BeyondSpring
Feb. 20, 2019 Helen Torley, M.B. Ch. B., Halozyme Pharmaceuticals Inc.
Feb. 27, 2019 Colleen Carter, Fingerpaint Aug. 28, 2019 Jennifer Gottlieb, W2O
Mar. 6, 2019 Melinda Richter, Johnson & Johnson Sep. 4, 2019 Anna Sundgren, Ph.D., AstraZeneca
Mar. 13, 2019 Gail Moore, Horizon Pharma Sep. 11, 2019 Carolyn Morgan, precisioneffect
Mar. 20, 2019 Shannon Dahl, Ph.D., Cell Care Sep. 18, 2019 Barbara Lopez Kunz, DIA
Therapeutics
Sep. 25, 2019 Meredith Terry, Ph.D., MicroMass
Mar. 27, 2019 Clareece West, Cardinal Health (former) Communications Inc.
Apr. 3, 2019 Deborah Dunsire, M.D., H. Lundbeck A/S Oct. 2, 2019 Peyton Howell, Parexel
Apr. 10, 2019 Liz Lewis, Takeda Pharmaceuticals Oct. 9, 2019 Jessica Scott, Takeda Pharmaceutical
Company
Apr. 17, 2019 Gisela Schwab, M.D., Exelixis Inc.
Oct. 16, 2019 Gwen Nichols, M.D., Leukemia &
Apr. 24, 2019 Sheri Madrid, Advanced Clinical
Lymphoma Society
May 1, 2019 Kathy Giusti, Multiple Myeloma Research
Oct. 23, 2019 Sophia Ononye, Ph.D., The Sophia
Foundation
Consulting Firm
May 8, 2019 Jayne Gershkowitz, Amicus
Oct. 30, 2019 Ahnal Purohit, Ph.D., Purohit Navigation
Therapeutics
Nov. 6, 2019 Kimberly Haugstad, Global Genes
May 15, 2019 Laurie Cooke, Healthcare
Businesswomen’s Association Nov. 13, 2019 Casey Lynch, Cortexyme
May 22, 2019 Ubavka DeNoble, M.D., Parexel Nov. 20, 2019 Laura Shafner, AiCure
Informatics
Nov. 27, 2019 Athena Countouriotis, M.D., Turning
May 29, 2019 Jessica Rousset, CURE Pharmaceutical Point Therapeutics
June 5, 2019 Lauri Bartolomeo, Dudnyk Dec. 4, 2019 Patricia Malone, FreshBlood
June 12, 2019 Joan Mannick, M.D., resTORbio Dec. 11, 2019 Corlis Murray, Abbott
June 19, 2019 Andrea Pfeifer, Ph.D., AC Immune Dec. 18, 2019 Kathy Vandebelt, Oracle
June 26, 2019 Shontelle Dodson, Astellas Dec. 25, 2019 Anne Heatherington, Ph.D., Takeda
WoW Woman of the Week • a 2019 Anthology 4 March 2020 • a Special PharmaVOICE Publication
Better Health, Brighter Future There is more that we can do to help improve people’s lives. Driven by passion to realize this goal, Takeda has been providing society with innovative life-changing medicines since our founding in 1781. As a leading global biopharmaceutical company, Takeda will always be unwavering in our contribution to bring better health and a brighter future to people worldwide. Diversity catalyzes bigger thinking, bolder visions and better results for the patients we serve. Takeda is committed to supporting an inclusive, equitable culture that enables our people to shine. We are proud to celebrate the achievements of women in science and healthcare every day, and especially on International Women’s Day. www.takeda.com
Maria Fardis, Ph.D.
President & CEO
Iovance Biotherapeutics Inc.
CAREER PATHS ARE TO BE DEFINED
BY YOU — NOT OTHERS.
Maria Fardis, Ph.D., is a scientist and
an expert in medicinal chemistry. Before
joining Iovance Biotherapeutics as
president and CEO, Dr. Fardis was chief
operating officer at Acerta Pharma,
where she worked on the development
of Calquence (acalabrutinib), until the
company’s acquisition by AstraZeneca.
Before joining Acerta, Dr. Fardis held the
position of chief of oncology operations
and alliances at Pharmacyclics, where
she oversaw development of Imbruvica
(ibrutinib). She was a key contributor
in the creation of a broad clinical
program for ibrutinib, as well as NDA Dr. Fardis believes that
and MAA submissions. During her time for female executives,
at Gilead, Dr. Fardis was involved with it is important to create
multiple therapeutic areas, including opportunities for the younger
antivirals, oncology, and cardiovascular generation. “And from my
therapeutics and worked on the perspective, the opportunity doesn’t
development and life-cycle management need to be gender-specific. We need
of Letairis. to think about other people’s careers
Leveraging her considerable and make sure that we provide a
experience in drug development, lending hand. It is our responsibility as
she is now one of the few women executives to watch after other people’s
CEOs and presidents of a biotech careers, the same way that someone
company — Iovance Biotherapeutics, might have watched after our careers. two-way collaboration with investors.
which is focused on the development We have a responsibility to develop our “I learned along the way that investors
and commercialization of autologous key members and the next generation of are partners…in our drug development
cellular immunotherapies optimizing drug developers.” program and journey,” she says. “Our
personalized, tumor infiltrating Drug development definitely is not for job as a management team is to do the
lymphocytes (TIL). the faint of heart, she says. “Bringing our right thing for the product and patients.
With a passion for science and best selves to work every day requires a We have to remember every day that
patients, Dr. Fardis has consistently number of factors. We have to start with we have to take the product further
put the goals of the project before her the end goal in mind and in any drug along in development and by doing that
personal career growth. “When I am development program that goal is to we not only do the patients and the
focused on accomplishing something, bring a product to the patients.” product good, but we create value and
the long hours are not long hours; they Under Dr. Fardis’ leadership, Iovance’s shareholder return on investment.” m
are not torturous,” she says. “I enjoy market cap has increased six-fold.
every minute. I’m doing exactly what I Part of creating value for the company
want to be doing with my day. I want to comes from her belief in establishing a
Listen to podcast
see the patient’s letter or the response
from a patient’s family member saying
WOW MOMENT: One of the best joys of anybody’s life in drug
how he or she is doing. I believe if you
are doing what you enjoy doing, it development is to see that label from the FDA when a product
doesn’t feel like a job. You are executing receives approval. It’s quite unparalleled. The excitement and
on your passion, and it’s just absolutely accomplishment of bringing a therapy to patients is unparalleled.
and utterly fun.”
WoW Woman of the Week • a 2019 Anthology 6 March 2020 • a Special PharmaVOICE Publication
Wendy White
Cofounder
RareiTi
THE THING THAT INSPIRES ME THE MOST IS
THE OPPORTUNITY FOR COLLABORATION.
Rare disease expert, author, marketer,
digital trailblazer, and serial entrepreneur WOW MOMENT: When my child was born with a rare disease, this
Wendy White is taking her vast industry changed my life. I re-focused my company and this continues to
experience and embarking on the next change my life, because Casey is amazing.
chapter of her journey as co-founder
of RareiTi, a new global system of
care for people and communities with unmet needs in the rare disease space. The common thread throughout
RareiTi offers managed access and Wendy’s journey is her passion for
medicines management programs patients as an innovative leader
that provide support beyond working at the intersection of advocacy,
therapy, combining care technology, and business in the rare
solutions that are specifically disease space.
developed, measured, She was named chair — a volunteer
and designed to improve role — of Global Genes in 2016. She
outcomes. evangelizes the nonprofit organization’s
Wendy’s focus on rare mission and dedication to the rare
disease was forged when disease community.
she re-centered her “Our mission is to start with the
start-up company patient and go ground up,” she says.
Siren Interactive “We know that fewer than 50% of the
to become one of 7,000 rare diseases have an organized
the breakthrough patient group. I truly believe that if you
entities in the rare do the right thing for the patient then
disease space you’re going to do the right thing for the
when her third business.”
child Casey Wendy is also a dedicated volunteer
was diagnosed within the Healthcare Businesswomen’s
with a rare Association, where she served as chair
connective tissue in 2015, during which time she laid the
disorder, which is groundwork for the organization’s focus
characterized by on gender parity throughout the life-
under-developed, sciences industry.
absent, or misplaced/ Whether as a volunteer leader or
misaligned kneecaps sitting in the C-suite, Wendy brings
in newborns. expertise and curiosity to the role.
Wendy was tireless “What has worked for me is becoming
in her pursuit to discover an expert,” she says. “My advice is to
what was wrong with Casey. become an expert in something specific,
Eventually, a doctor at Johns and hopefully something that you feel
Hopkins unlocked the mystery. passionate about. And the great thing
“It was a relief to get a diagnosis about that is then you can ask for
even though there are no therapies for sponsorship and mentorship.” m
people with connective tissue disorders,
but at least I had an idea of what was At the time of her WoW podcast, Wendy was
what going forward,” she says. Casey chief patient officer of Vitrisa Therapeutics.
is now 19, in college, and also a patient
advocate, in addition to trying to master
Listen to podcast
rock climbing and weight lifting.
WoW Woman of the Week • a 2019 Anthology 7 March 2020 • a Special PharmaVOICE Publication
More therapies are available in rare disease than ever before. But that doesn’t help
if patients don’t have access and pharma companies can’t show better outcomes.
BUILDING A
MISSION DRIVEN
MODEL THAT
MATTERS
RareiTi offers a new system of care for people and communities across the globe
with unmet needs in the rare disease space. Our managed access and medicines
management programs offer support beyond therapy, combining care solutions that
are specifically developed, carefully measured and designed to improve outcomes.
GLOBAL MANAGED ACCESS FOR
BETTER PATIENT OUTCOMES
RAREITI.COM
Rachel King
Cofounder and CEO
GlycoMimetics Inc.
I THINK IT’S IMPORTANT TO RECOGNIZE IN
THE MOMENT THE VALUE OF THE WORK THAT
WE’RE DOING AND THE COLLEAGUES WHO
WE ARE WORKING WITH.
Rachel King has seemingly done it
all. She started her career at the global
consultancy Bain and Company then
moved to the drug delivery company,
ALZA, and then on to several start-
ups, including Genetic Therapy (GTI),
which was sold to Novartis, then onto
an executive-in-residence role at New
Enterprise Associates (NEA), one of the
nation’s leading venture capital firms —
all before cofounding GlycoMimetics. “As
I reflect back, I feel fortunate, to have E-selectin inhibitor, to be
had opportunities to do work that I have used in combination with
found to be meaningful, interesting, and chemotherapy to treat patients
at many times fun. with acute myeloid leukemia
Rachel has always loved biology, a (AML) and potentially other
passion that has guided her career over hematologic cancers. The company
the years. “I’m driven by a desire to has had a mixed bag of results, and
connect that in my work although I’m after an initially stalled IPO, Rachel and
not a scientist and I’m not a physician,” her team successfully took the company
she says. “But I was one of those kids in public in 2014. She says the whole
high school who had a microscope and process was like pulling a rabbit out of a
a dissecting kit at home. I was a biology hat, and speaks to one of the company’s
geek at that point.” four core values: perseverance.
She has also been drawn to an “The other three are: passion, integrity, more easily get finance; and a focus
entrepreneurial setting and a desire and teamwork,” she says. “These give on messaging on the value story that
to work with people who she could insight into how we work and how we biotech brings.
learn from. After successful stints at feel about the company as we do these Rachel also serves on several boards,
Bain and Alza, she had the opportunity very difficult things.” including those of Novavax and the
to join GTI as the 12th employee. GTI In addition to setting the strategic University of Maryland’s Biopark, seats
was a startup company and the first direction for GlycoMimetics, Rachel was she gained due to the strength of her
company that had permission to do also chair of BIO — the Biotechnology network. “Getting to know people who
gene transfer experiments in humans Industry Organization — for two years. you respect and admire, and continuing
in the United States. In addition to the As part of the executive team, she to build relationships with those people,
great science, Rachel was involved helped lay the groundwork for what can bear fruit,” she says. m
with raising VC funding, taking the was to become the 21st Century Cures
company public, major collaborations, Act; capital formation — how to create
Listen to podcast
and the eventual sale to Novartis — all an environment where companies can
of which she says was foundational
to her starting GlycoMimetics.
GlycoMimetics pioneered the use of LESSONS LEARNED: Follow what you enjoy, that’s No. 1. And do it
glycobiology technology to understand with the best possible people. In my experience, opportunities have
the roles cellular carbohydrates play
come about through people I know.
in health and disease. The company’s
lead product is uproleselan, a specific
WoW Woman of the Week • a 2019 Anthology 9 March 2020 • a Special PharmaVOICE Publication
Jennifer De Camara
VP Law, US Pharmaceutical Strategic Customer Group
Johnson & Johnson
WE HAVE WORK TO DO IN OUR ORGANIZATIONS TO CONTINUE TO
LEVEL THE PLAYING FIELD AND MAKE SURE THAT OPPORTUNITIES
FOR ADVANCEMENT ARE BEING PROVIDED.
From an early age, Jennifer De Camara you have to think about how to make Jennifer has found working with J&J’s
recognized her own worth. She recalls your dreams come true and to take employee resource groups that support
a pivotal childhood experience with her responsibility for how are you going to women and their inclusion in leadership
grandmother, who noted that Jennifer get from your dreams to your reality.” is a lack of confidence in how to balance
was pointing out the most expensive With a double major in biology and career and home. There is a fear that
things in a shop window and that she political science, Jennifer has built a career advancement might further throw
would either need be a doctor or a successful career that encompasses that balance off and women may put
lawyer or marry one. “That really struck both of her passions. “I learned the off taking that next role until the kids
me because I remember immediately importance of merging the rigor of the are older. Additionally, women tend to
thinking why would I marry one if I scientific method and knowing what not take a role until they believe they
can be one,” Jennifer says. “This felt good science looks like with the legal are experts. “We need to give ourselves
like it was an important moment; thought process.” permission to learn as we advance,” she
Working for one of the largest says. “There are so many barriers that
pharmaceutical companies in the world, we disproportionately carry. I think it’s
Jennifer’s day is multifaceted, requiring critical that we take down these artificial
her to weigh in on a variety of topics. barriers.”
“I sit on the management board of our Jennifer is mindful of those who came
strategic customer group,” she says. before, women such as her grandmother,
“I advise our senior management on who also had a career in the law.
legal matters that support all levels of “I came into the story benefiting from
engagement with payers, institutional the chapters that were written by the
customers, and patient access generations before me — the women
and support programs, which is who fought for the right to vote and
set against a rapidly evolving who earned their way into the workforce
healthcare. I’m really fortunate to and made it normal, not just possible but
work with a lot of great people. normal, for me to go to law school and
The people who I work with are have the jobs that I’ve had,” she says. “I
smart. Their hearts are in the feel a responsibility that we’re writing
right places. We’re all trying to our chapter in the story right now, and I
help patients, so that part of my hope that the story ultimately concludes
day is always very enjoyable. My in a world that stops judging and
days are really interesting and I penalizing gender, color, or orientation,
never feel like I haven’t spent my which don’t matter to how well you can
time well during the day.” do the job or how good a person you
Jennifer is passionate about are. I feel very responsible to deliver to
the law, science, patients, as well my daughter and her friends as much as
as advocating for women and I can to that story ending as happily as
diversity in the workplace. “We know possible.” m
that women are not proportionately
represented in leadership roles and
so while we’ve come so far there is still Listen to podcast
so much more that needs to be done,”
she says. “It’s good for business, you
ADVICE: Trust your instincts and
get your best work product from a
diversity of thoughts, background, and don’t let uncomfortable questions
experiences.” go unanswered.
One of the commonalities that
WoW Woman of the Week • a 2019 Anthology 10 March 2020 • a Special PharmaVOICE PublicationLynn O’Connor Vos
President and CEO
Muscular Dystrophy Association
IN ANY BUSINESS, NONPROFIT OR FOR PROFIT, YOU
HAVE TO CONSTANTLY REINVENT YOURSELF.
Lynn O’Connor Vos’ successful career of new drugs that are coming to
has been multifaceted, from pediatric the market for neuromuscular
nursing, to technology, to leading a diseases. “MDA is a very big
global healthcare communications consumer brand that was put on
advertising agency, to her role today the map by Jerry Lewis in the
as president and CEO of the Muscular 1950s,” she says. “Today, we’re
Dystrophy Association (MDA) — the an umbrella organization that
70+ year-old nonprofit organization that recognizes a collection of more
is committed to saving and improving than 40 rare diseases.”
the lives of kids and adults living with Upon taking the CEO
muscular dystrophy and related life- role, now almost two years
threatening diseases. ago, Lynn’s focus has been
Underlying all of her success is a to heighten the brand so that
passion for patient care, advocacy, and everyone in the community
giving back. “I’ve always been involved knows that the MDA is the leading
with nonprofits; I was a founding board supporter of research and the largest
member of the Multiple Myeloma care center network and provider
Research Foundation (MMRF) and a of care support to patients with
founding board member of the JED neuromuscular disease. “From the get-
Foundation,” she says. go, it was quite obvious to me and my
Lynn also has been an active volunteer senior team that we needed to clearly
for the Healthcare Businesswomen’s communicate the value of MDA when it
Association, which named her its comes to research and care,” Lynn says.
Woman of the Year in 2005. They are careful to preserve some of something that can be
“What has struck me about most of MDA’s most well-known offerings, such developed.”
the nonprofits I’ve been engaged with as summer camp that hosts 4,000 kids As she reflects back on her career,
is that they are very disruptive,” she each year. She and her team are also Lynn wishes she had made a decade
says. “Certainly, Kathy Giusti, founder of looking to galvanize the organization by plan. “Another friend who I met through
the MMRF is recognized for pioneering offering unique technology solutions to HBA, also a Woman of the Year, Carolyn
a new way to bring drugs to market improve care. Buck Luce, talks about having a decade-
for cancer where there is absolutely Lynn believes one of the things that long plan,” Lynn says. “I was in the
nothing available. She herself was highly distinguishes successful people is what healthcare communications business for
motivated since she was diagnosed with she calls lateral or horizontal thinking. more than 20 years, and as I look back,
multiple myeloma at a very young age.” “These are people who can look at a I met a lot of milestones, I had a lot of
The JED Foundation, whose mission situation, make a quick assessment fun, and I did a lot of great things, but
is to protect the emotional health and from multiple data points, come up with if I had divided this time up into 10-year
prevent suicide for at-risk teens and ideas, and then package a solution that increments, I might have identified some
young adults, is also groundbreaking. drives consensus among the team to different goals. m
“Nobody was talking about suicide 14 get them to move forward,” she says.
or 15 years ago,” she says. “In fact, that “This type of leadership doesn’t come
was our biggest challenge: how do you naturally to everybody, but it’s certainly Listen to podcast
get people to donate and give to our
organization when nobody wanted to
talk about the stigma of suicide.”
Fast forward to today, and Lynn is C-SUITE ADVICE: First and foremost, you have to have an enormous
using all of the tools in her considerable degree of confidence in yourself. Become an expert at something; if
toolbox to evolve the MDA into a high- you’ve got a passion or a real expertise in an area, go for it.
science organization to take advantage
WoW Woman of the Week • a 2019 Anthology 11 March 2020 • a Special PharmaVOICE PublicationAmy Heymans
Founder and Chief Experience Officer
Mad*Pow
LISTEN TO YOUR INNER VOICE, HAVE FAITH IN YOURSELF,
AND DON’T SETTLE FOR LESS THAN YOU DESERVE.
Amy Heymans embodies the title
of chief experience officer. For her ADVICE: We talk about balance, but it’s about designing our lives to
there is nothing more important than include all of the things that fulfill us and then integrate them so they
involving the people who will be work together.
affected by solutions in the creative
process. She is using “human-centered
design” to change the current state of the healthcare in industry. This is the economics, as well as data science.“We
premise upon which she cofounded take our innovation philosophy and put
Mad*Pow. it into practice to improve the lives of
“Human-centered design is a term patients,” she says.
that reflects a philosophy and a To extend Mad*Pow’s reach, Amy
methodology that drives research and her team developed HxD, a health
to understand what drives design conference, more than 10 years
people’s behavior, their mental ago to explore the overlap of design,
model, their mindset, what innovation, and health. “The conference,
they’re facing, what they which draws more than 500 people,
need, what they desire, helps stimulate a dialogue about the
and what a positive application of human-centered design
experience for them in healthcare and how we can leverage
looks like,” she says. empathy and behavior changes design
“We then take that and psychology to improve the lives of
information and patients and clinicians.”
design with them, Amy brings her passion around
if possible, what an raising the importance of understanding
ideal experience the social determinants for health
would be like to her volunteer activities and
as they interact teacher roles, both of which she
with various says keep her grounded. “There is
organizations and an interconnectedness between
channels. We also health and finance and education and
create journey socioeconomic status,” she says.
maps to envision a Carving out an entrepreneurial path,
more positive future creating a visionary strategy, and
and bring this to ideating on a world-class level often
bear through patient doesn’t leave a lot of time for a balanced
support materials, life. To avoid burnout, Amy has learned
digital materials, to be more forgiving to herself. “With
human-to-human so many balls in the air, aiming for
interactions, etc.” perfection with everything can drive you
Amy and her crazy,” she says. “I had to let the house
team strive to be messy. I had to ask for another day to
solve complicated work on a project. Learning to prioritize
health issues and and say no to a few things is still a
crack the code on how challenge for me, to be honest, but the
to design for engagement, better I am at it the better things go.” m
which involves the overlap of several
disciplines: motivational psychology,
Listen to podcast
behavioral science, behavioral
WoW Woman of the Week • a 2019 Anthology 12 March 2020 • a Special PharmaVOICE PublicationHEALTH See HXDconf.com for information
on dates, schedule and registration.
EXPERIENCE
DESIGN
@HXDconf
Improving Health
Through Design &
Experience Innovation
HXD provides a unique crossroads
for a diverse community of
executives and practitioners in
design, innovation, research, strategy,
and technology to come together
and discuss how we might improve
Join Amy Heymans,
health experience and accelerate the
Mad*Pow Founder and
transformation of our health system.
CXO at Mad*Pow’s annual
Health Experience Design Register using code PHARMAVOICE
Conference in Boston. and save $250 off current prices.Georgia Mitsi, Ph.D.
Senior Director, Search and Evaluation, Digital Healthcare
Sunovion Pharmaceuticals
I HAVE LEARNED THAT BEING
COMFORTABLE WITH THE
UNCOMFORTABLE IS A GREAT
LIFE SKILL; SOMETIMES 50% OF
SUCCESS IS JUST SHOWING UP.
The fact is Dr. Georgia Mitsi loves
learning new things — she has an MBA,
a Ph.D., a masters in applied medical
science, and a bachelors degree in
biology. She also loves taking on
challenging pathways. Both of which
were more than enough motivation
for her to not just dive into the digital
healthcare arena, but to become a top the
thought leader on the subject matter. chance
“At the end of the day, the digital to go
world opens up endless possibilities back in
and brings a sense of hope and time and
optimism,” Georgia says. “I do not talk to myself 20
believe that technology is a panacea years ago I would say
nor do I see technology as a substitute you’re good enough, just trust
for the expertise of doctors, but I do yourself and move on.”
believe that technology has the unique Georgia is passionate and
ability to restore trust and provide the driven every day to address the
opportunity for more empathetic and needs of people who suffer from
in-depth interactions between patients chronic conditions and who struggle
and doctors.” to find the right resources or medical
Georgia believes technology will therapies.
allow doctors to do what they do best, “This is a fight worth fighting; I am
provide care. always driven by a higher purpose,
“At the same time, for pharmaceutical which is my calling in life,” Georgia says.
companies, I envision that technologies, Georgia is also a passionate supporter times experienced inequality. I dream
especially advanced analytics and data of women and is committed to moving of the day and a world in which gender
science, will allow us to go beyond the the needle on gender parity through a parity is attainable; I believe that we
traditional regulatory pathway and bring number of volunteer activities. can change the world with a little bit of
the right treatments for patients to the “We still live in an era where there is so coordination from both men and women
market faster.” much more work to be done to achieve who are supportive of its future.” m
Georgia self-identifies as an introvert, gender parity in the life-sciences field,”
and recognizes that it can be nerve- she says. “As a mother, as an immigrant
racking at times to push through one’s — I moved to the U.S. from Greece when Listen to podcast
safety zone. I was 30 — and as a woman I have at
“I have learned that being
comfortable with the uncomfortable is a ADVICE: Careers are a marathon — not a sprint. We need to
great life skill; sometimes 50% of success
remember to laugh; I have taken my life and sometimes myself too
is just showing up,” she says. “I think
many women just like me strive to be seriously, smiling is a good thing, it brings people closer to you.
perfect and we doubt ourselves; if I had
WoW Woman of the Week • a 2019 Anthology 14 March 2020 • a Special PharmaVOICE PublicationHelen Torley, M.B., Ch.B.
President and CEO
Halozyme
I HAVE A PASSIONATE DESIRE TO MAKE A
DIFFERENCE IN THE LIVES OF PATIENTS.
Dr. Helen Torley made a significant “My desire to become a CEO was the works together to realize the company’s
leap into the C-suite just over five years logical next step in my career; I’ve been strategy and to build a great culture.
ago when she left Onyx Pharmaceuticals, in the pharmaceutical industry about 30 “Many companies fail because they don’t
where she was executive VP and chief years,” she says. have a cohesive leadership team. I’m
commercial officer, to become president Dr. Torley, who started her career as very proud of both the technical skills
and CEO of Halozyme. While at Onxy, a rheumatologist in clinical practice, we have on the leadership team, but also
she oversaw the collaboration with joined the industry initially in clinical how we support each other to assure
Bayer on Nexavar and Stivarga and the development then moved into business success,” she says. “We have a
U.S. launch of Kyprolis; she also was marketing positions and business very clear set of expectations as to how
responsible for the development of leadership positions. “I have had many the entire company works together. We
Onyx’s commercial capabilities in ex-U.S. different experiences, which led to my have a great culture where employees
markets. becoming a leader of a great company,” feel inspired and energized to work.”
she says. Dr. Torley recommends The Five
According to Dr. Torley, Halozyme has Dysfunctions of a Team by Patrick
a unique business model. “One-half of Lencioni, which she says sets out the
our business is focused on partnerships principles of how to build cohesive
through our Enhanze technology and teams that have each other’s backs in
the other part of the business is focused good times and in bad times. “One of
on proprietary noble drug development, most important tenets of this is building
including a drug for patients with trust, knowing that we might not always
pancreatic cancer.” know the answer and are willing to be
Halozyme’s Enhanze drug delivery vulnerable to ask for help,” she says.
technology enables biologics Dr. Torley says her career was boosted
and small molecules currently through the support of sponsors, one in
administered intravenously to particular who recognized her talents
be delivered subcutaneously. early on and put her in an important
The technology is based on leadership position overseeing a large
the company’s proprietary piece of the company’s P&L. “If this
recombinant human hadn’t happened, my career would have
hyaluronidase PH20 enzyme been very different,” she says. “I think
(rHuPH20) that degrades it’s really important that companies
hyaluronan, or HA. HA is a consider sponsorship programs for
glycosaminoglycan, a chain those employees they believe have high
of natural sugars that is a potential, the people who will be future
component of normal tissue, such leaders of large functions or divisions.
as skin and cartilage and can also It’s important to take them out of their
accumulate around many solid comfort zone and see how agile they
cancerous tumors. really are. There is nothing quite like
One of the keys to Halozyme’s this in terms of an accelerated learning
success is based on Dr. Torley’s environment.” m
commitment to building a strong and
high-functioning executive team that Listen to podcast
ADVICE: Sponsorship is making a bet on somebody who has shown
potential and who you believe has the leadership qualities to be able to
scale into a new role.
WoW Woman of the Week • a 2019 Anthology 15 March 2020 • a Special PharmaVOICE PublicationColleen Carter
Marketing & Business Development
Fingerpaint
SUCCESS IS ABOUT HAVING A
PURPOSEFUL LIFE WITH MEANING.
Early in her career Colleen Carter place — to get lifesaving medicines
was inspired by a leadership concept into the hands of those who need
that has guided her career ever since. them most.”
“I was selected to attend an executive Colleen believes the strength
leadership program at Babson,” she says. of the relationships that
“In one of the courses, the professor she builds with her clients
asked us to think about all of the people and the work that comes
on our path who taught us what we out of those relationships
needed to know to be the leaders who helps her and her teams
we are today or who inspired us to be deliver on that goal. “I
a leader to grow into. These individuals often think about the
could be bosses, colleagues, teachers, awesome responsibility of
family members, etc. I remember I had this,” she says. “We need
my grandmother on my list. After we to care about our clients.
put their names on a flip chart we had to We need to care about
present back to the class what we had these brands truly
learned from every person on our flip as much as our
chart. It was fascinating to hear other clients do.
people’s stories about how connections And when
and relationships had impacted them. we make
The thing that has stuck with me all promises,
these years is when the professor we need
asked us to consider our own lives and to be
consider how many flip charts would prepared
have our name on them. This was a to deliver
really powerful moment for me because on them.
we have so many opportunities every Ultimately,
day to make it onto someone’s flip chart. our efforts
I think about this exercise often in small affect our
ways and big ways. This was a wow clients’ successes.”
moment. We don’t get to where we are Colleen has several so proud that I want to put my
by ourselves. There are many people guiding principles that signature on it?” she says. “These are
along the path who helped get us there. shape her personal and professional the things that define success for me
And I want to make it on to people’s flip life. “At Fingerpaint, we have three core today. It isn’t just success in a career;
charts.” pillars that speak to the work that we it’s success in life. I’m the same person
As a seasoned advertising executive, do, and they extend into the lives that who shows up at work as who shows up
relationships are Colleen’s stock-in-trade. we lead,” she says. “The first is what I’m at home, and so it has to work in both
She has made a career out of building doing ‘paint by number?’ The second areas.” m
and nurturing personal connections with is ‘can I see the difference this will
colleagues, peers, and clients. make?’ And the third is ‘is it worth my Listen to podcast
“Relationships are all about honesty, signature?’”
trust, respect, and communication,” she For Colleen, the answers to these
says. “Ultimately, our efforts affect our questions define success. “Am I thinking WOW MOMENT: We don’t get to
client successes. Their careers and their differently? Am I making a difference
where we are by ourselves. There
reputations can sometimes be affected in the people in my life, in the lives of
by what we deliver or don’t deliver. At those I serve, in the people who I know, are many people along the path
the end of the day we have to remember and the people who I don’t know? Am that got us there.
why we do what we all do in the first I proud of the work that I’m doing,
WoW Woman of the Week • a 2019 Anthology 16 March 2020 • a Special PharmaVOICE PublicationMelinda Richter
Global Head
JLABS, Johnson & Johnson
I SEE SO MANY WOMEN WHO SAY ‘NO, I CAN’T DO THAT.’ FROM NOW ON,
I WANT THEM TO SAY YES AND FIND THE SUPPORT THEY NEED TO MAKE IT WORK.
Melinda Richter’s journey has taken in one moment everything changed — wasn’t where I intended to go but I’m so
her from patient to innovation champion she found herself near death after being glad this is where I got to.”
to one of the most influential women bitten by a bug. “I’ll never forget that Taking lessons from her tech days,
in the life-sciences industry today. Her moment when the doctors came in and Melinda’s goal was to create a user
accidental entry into healthcare began told me that there’s nothing more they experience for the healthcare system
in Beijing, where she was on the fast can do for me,” she says. “That set off a that allows patients to be empowered,
track at a global telecom company, and two-month journey where every night I engage in their health, and to make
would go to sleep not knowing whether decisions that lessen the stress. At the
I was going to wake up the next day. same time, she believes it’s important
There are conversations that happen in to have the right model in place to
your head in the deep dark of night. And incentivize entrepreneurs and investors
for me, I knew that if I got the chance to come to the table.
to live that I had to try to change the “We look to see what the system
experience that I was going through.” needs to make it a high-functioning
Her goal was to change the system for everybody,” she says. “Our
healthcare system to become much philosophy is that the best science and
more innovative, productive, technology should become the best
advanced, and sexier to attract solutions for patients and consumers all
the best talent and the best over the world. And if we believe that
investors. “I quit my job,” to be true, we also have to be humble
Melinda says. “Everybody enough to say the best science and
in my company thought technology are just as likely to come
I was absolutely crazy. I from outside the walls of a big company
said I wasn’t crazy, I was like J&J as inside. Our job at JLABS is to
compelled.” locally embed ourselves in innovation
She vowed to change ecosystems around the world with the
how the industry innovated. express intention to take down the
She started by asking hurdles for entrepreneurs and give them
questions, bringing together the platform they need to test their
biotech entrepreneurs with ideas in a way that can make it much
executives from big pharma faster, much cheaper, and much more
companies, and learning the accessible to get those solutions to the
process of innovation. “I didn’t people who need them.”
think I was going to make a big Currently, Melinda and the JLAB’s
system change, I just wanted to team have opened more than a dozen
start a little bit at a time,” Melinda global innovation sites and assisted
says. “I started to build a model — a hundreds of companies. m
brick at a time — that has turned in
to JLABS, part of Johnson & Johnson
innovation. It’s humbling to see where
Listen to podcast
I’ve landed in that journey. It certainly
ADVICE: Life expands or contracts in direct proportion to your
courage. So have courage, go after what you want because you
will reap the rewards. We’re all scared — this is just table stakes for
everybody, so know it, put it on the table, and then do it.
WoW Woman of the Week • a 2019 Anthology 17 March 2020 • a Special PharmaVOICE PublicationGail Moore
Director, Global Patient Advocacy
Horizon Pharma
I HAVE THE BEST JOB IN THE WORLD BECAUSE
I GET TO GIVE BACK AND REPRESENT PATIENTS’
VOICES WITHIN OUR COMPANY AND ALSO IN
THE COMMUNITY ITSELF.
As a patient with a rare disease and college. “They’re
a parent of a child living with a rare both independent,
disease, Gail Moore’s role as director productive citizens
of global patient advocacy at Horizon who are out in the
Pharma is not just a job — it’s a passion workforce and living
and a mission. their best life,” she
Gail’s odyssey began 22 years ago says. “That’s what
with the birth of her first child. Her every parent can
daughter Kinsey was hospitalized hope for. For myself,
just four weeks after being born I still walk that line
with an infection — salmonella in her as a patient and an
bloodstream — a medical mystery. Over advocate for patients.”
the next four years, Kinsey continued Her advice for
to contract strange infections, many of parents who may be
which were life-threatening, ultimately facing a similar situation
being diagnosed with a primary immune is to learn everything they
deficiency. This diagnosis led Gail and can about the condition,
the medical team to delve into her and don’t take no for an
her husband’s family histories. As it answer, and become
turned out, Gail’s mother, who had been their own best
sick most of her life was also diagnosed, healthcare
as well as herself and her son, who was advocate.
18 months younger than Kinsey. “I lived “There is a
in a doctor’s office; Kinsey would get need for more
an infection and then my son Garrett education about diseases and then
would get it and they’d both end up in and thankfully I look for opportunities
the hospital,” she recalls. “Before having science is to collaborate to benefit
children, I worked in a professional growing rapidly; the community in general. I
capacity for a hospital, and I knew what as a parent or as have the best job in the world
was happening to me wasn’t normal. a patient with a rare because I get to give back and
Ultimately, I became very engaged with disease, you need to be represent patients’ voices within
the patient community — the Immune as educated as you can be our company and also in the community
Deficiency Foundation — that was so that you can go back and share that itself. I want my legacy to be that in
supporting our diagnosis of primary knowledge with your physicians and some way along the way I’ve made
immune deficiencies. Through that your healthcare team — this way you’re someone’s life a little bit easier.” m
engagement I became an advocate, and doing everything you can for your child
ultimately this led me to my career in or yourself,” she says.
Listen to podcast
healthcare.” In her role at Horizon, Gail works
The advocacy organization opened with national and global patient
a lot of doors for Gail, and ultimately organizations associated with the WOW MOMENT: I’m doing what I
she was asked to be the patient’s voice medications and communities the
love doing and I’m able to make
inside the industry side of the business. company serves. “I am literally the
“I’ve been doing this for the last 12 liaison between Horizon and patient a difference in an area in which
years,” she says. organizations,” she says. “I represent a lot of people don’t have an
Today, both of Gail’s children are their voice internally. I educate both opportunity to do so.
doing well, having graduated from internal and external stakeholders
WoW Woman of the Week • a 2019 Anthology 18 March 2020 • a Special PharmaVOICE PublicationShannon Dahl, Ph.D.
Chief Scientific Officer
Cell Care Therapeutics
CHALLENGES ARE REALLY
OPPORTUNITIES FOR INNOVATION.
Shannon Dahl, Ph.D.’s pursuit of
regenerative medicine and tissue
ADVICE: My unique value is focused on being very comfortable at the
engineering began back in the 1990s edge of ambiguity and using five skills to define the path forward; it’s
while she was at MIT. At that time the about clearly formulating the value proposition, driving priorities to realize
field was just emerging, and Shannon strategic goals, developing rigorous data sets to support decision making,
was excited about the potential of putting a stake in the ground with strong rationale and justification, and
offering natural solutions rather than
collaborating with internal and external stakeholder teams.
synthetic medical devices to treat
patients. She joined fellow Duke
University alums — Laura Niklason, M.D., platform for vascular surgery. The Shannon is a prolific innovator with
Ph.D., and Juliana Blum — to found technology provides an “off-the-shelf” more than 20 patents to her name.
Humacyte. In 2003, the three began bioengineered human acellular vessel “I’m ultimately focused on bringing
laying the groundwork for the company that could replace a patient’s own blood innovative therapies forward to help
and Humacyte launched in 2004 to vessel or create new vascular access for improve patient care and it’s an
advance a bioengineered blood vessel patients who require dialysis, without added bonus if these products reduce
requiring cells or tissue from the patient. healthcare costs,” she says. “Innovation
At the time, Shannon knew and requires new ways of thinking about
appreciated that she and her colleagues the interface of technology, strategy,
were embarking on new territory. Their healthcare, and policy.
work was recognized in 2016 by CNBC In ascending to the C-suite, Shannon
as a top Disruptor 50 company. “This says it’s important to continuously
was the same year that the Disruptor develop yourself and to be courageous
50 recognized Uber, Airbnb, an about knowing your key value.
23andMe,” she says. “Becoming a good leader requires taking
In addition to being a world- stock of who you are and knowing your
class regenerative medicine value, strengths, and the impact you
leader, Shannon has a want to make so that you can focus your
reputation as a company efforts with intention,” she says. “Good
builder who defines a clear executives pay attention to how they
path forward from early interact with others, they know how to
research to clinical trials, have teams work effectively together,
commercialization, and they know how to engage others, they
reimbursement. learn from others, and they develop
In 2018, Shannon left and coach others to build a pipeline of
Humacyte, in her own words, leaders for the industry.”
“to do it all again.” She was Shannon also enjoys giving back to
named chief scientific officer the scientific community. She serves as
of Cell Care Therapeutics, a mentor at Stanford StartX Med, which
which is developing novel is a medical vertical of StartX. “I enjoy
therapies derived from the meeting these energetic, early-stage
secretions of adult stem cells founders, simultaneously I get to see a
to treat severe inflammatory broad range of interesting technologies
and degenerative retinal diseases across several sectors that are spinning
in patients who suffer from vision out of the institution.” m
loss. “We are offering a new type of
off-the-shelf treatment for patients
by harnessing the body’s natural
Listen to podcast
regenerative capacity,” she says.
WoW Woman of the Week • a 2019 Anthology 19 March 2020 • a Special PharmaVOICE PublicationClareece West
Former VP, General Manager
Cardinal Health
I BELIEVE YOU HAVE TO BE MORALLY GROUNDED
AND COME TO THE TABLE WITH A CAN-DO,
COLLABORATIVE, TEAM-DRIVEN MINDSET.
Clareece West has had a varied and industry has an impact on
successful career over the past 25 a patient. So, stay the extra
years. She has had leadership executive minute, put the extra time
positions at two Fortune 500 companies in, and do the right thing
and two large CROs. She has been because that patient can be
part of several restructuring initiatives, anybody, whether it’s you,
including six acquisitions, and built large me, or someone we love. I
business development teams, while may not be a nurse, I may
gaining global expertise. not be a doctor, but I know
And through it all, the biggest reward everything that I, we, do in
for Clareece is seeing the excitement this industry has an incredible
from her teams to independently drive impact for the outcome of a
initiatives. “When I think about what patient.”
all these experiences have in common, She is equally passionate
whether it was building business about paying it forward through
development or operational teams or her volunteer activities with
leading through an acquisition, the a number of organizations. For
reward was truly seeing the potential of example, Clareece is a founding
a talented team and how to harness that member of the Women’s Capital
talent for sustainable growth,” she says. Connection, which is a regional angel
“I love giving back all of the knowledge investment group; she is an active
that I’ve been so fortunate to gain along member of the Mid-America Angel
my journey.” Investors Network; she works with home it helps
Clareece has a passion for marrying the Ewing Kauffman Foundation as a put into perspective
science and technology to improve and reviewer of some of the organization’s how important volunteering is, how
advance devices and therapies for all business awards; and she is a volunteer important donating is — whether that’s
patients. “Where the industry is heading, with the Healthcare Businesswomen’s time or money, both very much matter.”
the two are virtually inseparable,” she Association. Clareece firmly believes in creating
says. “We won’t be able to improve “I feel extremely privileged and an action plan for one’s career and life.
patient therapies, nor will we improve grateful for a very long career in “I stop and assess my goals annually,”
the impact of medical devices, without leadership and executive positions, she says. “If you’re not planning to
this powerful combination. I firmly which compels me to want to share and be successful, you’re not going to be
believe that technology can help us give back,” she says. “I can’t tell you how successful. Our lives are a series of
expand science when carefully used. It much I enjoy this piece of it. I would chapters that make up a book, and I’m
forces all of us to think differently, be love to volunteer even more as I feel under the impression that we get to
a bit more innovative, and to push our that volunteering is part of community write most of them.” m
market ahead especially for regulatory stewardship and my personal passion
pathways and clinical trials as I’ve done is the Alzheimer’s Foundation as well
over the years.” as Kansas City Hospice House. When Listen to podcast
Clareece is driven to do what’s right diseases and opportunities hit close to
for patients. “Early in my career, my
mentor coached me on the importance
ADVICE: I would remind everyone to stop and assess your goals
of putting the patient first,” she says.
“I will be passionate until I don’t have annually. If you’re not planning to be successful, you’re not going
a heartbeat about putting the patient to be successful.
first. Every decision we make in this
WoW Woman of the Week • a 2019 Anthology 20 March 2020 • a Special PharmaVOICE PublicationDeborah Dunsire, M.D.
President and CEO
H. Lundbeck A/S
ONE OF THE WAYS THAT I LOOK AT SUCCESS IS BY THE SUCCESS OF
THE PEOPLE WHO HAVE WORKED WITH ME. IT’S SO REWARDING TO
SEE PEOPLE WHO I’VE WORKED WITH NOW AS CEOS.
Deborah Dunsire, M.D., president transformative, and address areas where no therapies,” she says. “So in pursuing
and CEO of H. Lundbeck A/S, is one of there is a high unmet medical need,” something that I found intellectually
the top-ranking women executives, as she says. “Brain disease is certainly one and emotionally captivating, I went on a
well as one of the most admired, in the of those frontiers. I believe we’re at the journey that I never expected.”
pharmaceutical industry. As a testament beginning of a new wave in treating Throughout her career, Deborah has
to her inspiring leadership, Deborah diseases of the brain. We’re starting to held a variety of roles from clinical
was named Woman of the Year by the understand the biology much better and research to global marketing to sales
Healthcare Businesswomen’s Association we are thinking differently about the and marketing, to new product planning,
in 2009. subsets of patients for whom we can and ultimately to company leadership
She is a transformative leader, whose get the right therapy. bringing together all aspects of the
focus on the patient never waivers. “My “Our vision is to have every person be value chain from basic research all the
passion is to help people attain new able to live their best life uninterrupted way through to bringing medicines to
medicines, develop medicines that are by brain disease,” she continues. “In patients.
the next 12 months we’ll be moving “I have worked in multiple different
some products forward in our pipeline; countries — South Africa, Switzerland,
for instance, in post-traumatic stress the United States, and now in Denmark
disorder, which is an area that’s growing — and across the world the commonality
and has no adequate therapies as has been bringing forward new
yet. We’ll also be strengthening the medicines that can be transforming,” she
pipeline of Lundbeck through external says.
partnerships, licensing, or acquisition.” Patients have been at the core of
In early March 2020, Lundbeck everything Deborah does since she
announced the U.S. FDA had approved started in the industry in South Africa in
Vyepti, making it the first and the late 1980s, working with Sandoz on
only FDA-approved intravenous organ transplantation and the launch of
treatment for migraine prevention Novartis’ Gleevec — the first targeted
in adults. Vyepti is expected to oncology agent.
be available in April 2020. “I still correspond with a woman
Deborah’s journey to the who was in the Phase I trial of Gleevec;
C-suite may not have been it’s now 20 years out since she was
one she anticipated but diagnosed with chronic myelogenous
it’s certainly one that has leukemia,” Deborah says. “She’s raising
positioned her as a role model money for the Leukemia & Lymphoma
to thousands of women. Society, working, and running
“I came into the industry marathons. She inspires me. For me,
thinking I would be here the wow moments have always been
temporarily, just gaining a little about when we are able to successfully
knowledge and understanding, transform science into medicine. We
but I was captivated by the want people to be their best and that’s
degree of different skills that why we work every day.” m
are required to bring a new
medicine forward as well as by the
Listen to podcast
opportunity to work on diseases with
WOW MOMENT: The wow moments have always been about
when we are able to successfully transform science into medicine.
WoW Woman of the Week • a 2019 Anthology 21 March 2020 • a Special PharmaVOICE PublicationYou can also read
